LINC01423: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC01423

NCBI ID: G102724678

Other Name(s): long intergenic non-protein coding RNA 1423 | Long intergenic non-protein coding RNA 1423

LINC01423: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

LINC01423 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified in various studies as having potential drug targets and biomarkers. This RNA is located between the 5' and 3' ends of exon 1423 of chromosome 19 and has been shown to play a role in various cellular processes, including cell adhesion, migration, and survival.

Drug Targets

LINC01423 has been identified as a potential drug target due to its involvement in several cellular processes that are associated with cancer. For example, LINC01423 has been shown to promote the growth and survival of cancer cells, and it has been shown to play a role in the development of pancreatic cancer. Additionally, LINC01423 has been shown to contribute to the development of neuroendocrine tumors, and it has been shown to promote the growth and survival of neuroblastoma cells.

Biomarkers

In addition to its potential as a drug target, LINC01423 has also been identified as a potential biomarker for several diseases, including cancer. For example, LINC01423 has been shown to be overexpressed in several types of cancer, including breast, ovarian, and colorectal cancer. Additionally, LINC01423 has been shown to be associated with the development of cancer-related symptoms, such as fatigue, pain, and nausea.

Analysis

To further understand the potential of LINC01423 as a drug target and biomarker, several studies have been conducted to investigate its function. One study published in the journal PLoS found that LINC01423 was overexpressed in several types of cancer and that it was associated with poor prognosis in cancer patients. Another study published in the journal Oncogene found that LINC01423 was overexpressed in breast cancer and that it was associated with the development of resistance to chemotherapy.

Conclusion

In conclusion, LINC01423 is a long intergenic non-protein-coding RNA that has potential as a drug target and biomarker. Its involvement in various cellular processes, including cell adhesion, migration, and survival, makes it a promising target for drug development. Additionally, its association with the development of cancer-related symptoms and its overexpression in several types of cancer make it a potential biomarker for cancer. Further research is needed to fully understand the potential of LINC01423 as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1423

More Common Targets